The effects of six months of multi-level workplace interventions aimed at decreasing sedentary behavior.
Three more I-Mab execs exit after US/China operations split
As I-Mab Biopharma embarks on its next chapter as a fully US-based company, it’s parting ways with more executives from the old era. Chief Business